Cedar Health Research: Company Profile

Background

Mission and Vision

Cedar Health Research is dedicated to providing clinical research as a care option for communities, ensuring that clinical trial populations accurately represent the patients who bear the burden of disease. Their vision is to be the gold standard for community-based research, partnering with local healthcare practices and utilizing electronic medical record (EMR) abstraction technology to function as the research arm for numerous community providers. They aim to offer all patients who could benefit from participation in a clinical trial the opportunity, ensuring a seamless, safe, and positive experience as part of their holistic care.

Primary Area of Focus and Industry Significance

Established in 2019 and headquartered in Dallas, Texas, Cedar Health Research operates as an independent, multi-therapeutic clinical research site and patient network. The company focuses on expanding access to clinical research studies within Texas by partnering with a diverse group of healthcare providers. Their innovative approach aims to bridge the gap between underserved communities and clinical trials, enhancing the inclusivity and diversity of clinical research data.

Key Strategic Focus

Core Objectives

Expand Access to Clinical Trials: By partnering with local healthcare providers, Cedar Health Research aims to increase patient participation in clinical studies, particularly among underserved populations.

Enhance Diversity in Research: The company is committed to ensuring that clinical trial populations reflect the demographics of the communities they serve, addressing historical underrepresentation in clinical data.

Specific Areas of Specialization

Multi-Therapeutic Research: Cedar Health Research conducts studies across various therapeutic areas, including vaccines, neurology, metabolic diseases, women's health, cardiovascular, endocrinology, and general medicine.

Community-Based Research: The company specializes in integrating clinical research into community healthcare settings, reducing barriers such as travel and limited access to research facilities.

Key Technologies Utilized

Aspen Forge Platform: This technology enables direct integration with healthcare partners' EMRs, facilitating accurate population analytics, data-driven feasibility analyses, and robust candidate identification.

RealTime CTMS Integration: Cedar Health Research utilizes RealTime CTMS for study tracking, integrated directly into Aspen Forge, to streamline study management and patient recruitment processes.

Primary Markets Targeted

Underserved Communities in Texas: The company focuses on increasing access to clinical trials for populations that have historically been underrepresented in clinical research, particularly within Texas.

Financials and Funding

As of the latest available information, Cedar Health Research has not publicly disclosed specific details regarding its funding history, total funds raised, or notable investors. The company continues to expand its operations and partnerships, indicating a positive financial trajectory.

Pipeline Development

Cedar Health Research has been involved in various clinical trials across multiple therapeutic areas. Notable achievements include:

Top Enrolling Site: Pediatric Constipation Study

Top Enrolling Site: Phase 1 Pediatric Migraine Study

Top Enrolling Site: Women’s Stress Incontinence Device

Top Enrolling Site: Women’s Health Diagnostic Device Study

Highest Enrollment Rate: Endometriosis

#2 Enrolling Site in the U.S.: Complex Adolescent Vaccine Study

Highest Enrollment Rate: Adult Migraine Trial

These accomplishments highlight the company's capability in managing and executing complex clinical trials with diverse patient populations.

Technological Platform and Innovation

Proprietary Technologies

Aspen Forge: A technology platform that securely connects with healthcare partners' EMRs to support accurate population analytics, data-driven feasibility analyses, and robust candidate identification.

Significant Scientific Methods

AI-Driven Patient Matching: Utilizing artificial intelligence to analyze patient data and match individuals with appropriate clinical trials, enhancing recruitment efficiency and study success rates.

Leadership Team

Todd Albin: Chief Executive Officer

Todd Albin serves as the CEO of Cedar Health Research, leading the company's strategic direction and operations. Under his leadership, the company has expanded its clinical research sites and strengthened partnerships with healthcare providers.

Ezekiel Fink, M.D.: Chief Medical Officer

Dr. Ezekiel Fink serves as the Chief Medical Officer, overseeing the clinical aspects of the company's research initiatives. His expertise ensures that Cedar Health Research maintains high standards in patient care and clinical trial execution.

Competitor Profile

Market Insights and Dynamics

The clinical research industry is experiencing significant growth, driven by the increasing complexity of clinical trials and the need for diverse patient populations. Companies like Cedar Health Research are well-positioned to capitalize on this trend by offering innovative solutions that integrate clinical research into community healthcare settings.

Competitor Analysis

Medidata: A leading provider of cloud-based solutions for clinical trials, offering a comprehensive suite of tools for study planning, execution, and data analysis.

Verily: An Alphabet subsidiary focused on life sciences and healthcare, developing tools and devices to collect, organize, and activate health data.

TriNetX: A global health research network that connects healthcare organizations, biopharmaceutical companies, and contract research organizations to accelerate clinical research.

Signant Health: Provides eSource and clinical trial management solutions, including electronic data capture, patient engagement, and analytics.

WIRB-Copernicus Group: A global provider of outsourced services for the clinical research industry, including institutional review board services and clinical trial management.

Strategic Collaborations and Partnerships

Cedar Health Research has established significant collaborations to enhance its research capabilities and expand patient access:

Texas Native Health: In February 2026, Cedar Health Research and Texas Native Health expanded their partnership by opening a new embedded clinical research site within Texas Native Health. This initiative aims to increase access to clinical trials for Native American patients, a population historically underrepresented in clinical research.

Eli Lilly and Company & Amgen: The new embedded site will initially conduct clinical trials with these pharmaceutical companies, focusing on conditions disproportionately affecting Native American populations, such as cardiometabolic diseases.

Operational Insights

Cedar Health Research's strategic focus on integrating clinical research into community healthcare settings provides a distinct competitive advantage. By reducing barriers to participation and ensuring diverse patient representation, the company enhances the quality and applicability of clinical trial data. This approach not only benefits patients but also offers valuable insights to sponsors and contract research organizations.

Strategic Opportunities and Future Directions

Cedar Health Research is well-positioned to expand its network of community partnerships, further integrating clinical research into diverse healthcare settings. By leveraging its technological platforms and commitment to inclusivity, the company can continue to enhance patient recruitment, improve study outcomes, and contribute to the advancement of medical knowledge.